Human MVP(Major Vault Protein) ELISA Kit
Contact us: [email protected]
 ELISA Kit) Human Major Vault Protein (MVP) ELISA Kit |
|
RDR-MVP-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 652.8 |
Human Major Vault Protein (MVP) ELISA Kit |
|
RDR-MVP-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 907.2 |
) Human Major vault protein (MVP) |
|
1-CSB-EP015248HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Major vault protein(MVP) expressed in E.coli |
Human Major Vault Protein (MVP) ELISA Kit |
|
20-abx152259 |
Abbexa |
-
EUR 8534.40
-
EUR 4550.40
-
EUR 1054.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Major Vault Protein (MVP) ELISA Kit |
|
abx250461-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
|
Human Major Vault Protein (MVP) ELISA Kit |
|
abx354408-96tests |
Abbexa |
96 tests |
EUR 943.2 |
|
|
 human major vault protein,MVP ELISA Kit |
|
201-12-1650 |
SunredBio |
96 tests |
EUR 528 |
|
|
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
 ELISA Kit) Human MVP(Major vault protein) ELISA Kit |
|
EH1206 |
FN Test |
96T |
EUR 681.12 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
 Human MVP/ Major vault protein ELISA Kit |
|
E1680Hu |
Sunlong |
1 Kit |
EUR 685.2 |
ELISA Kit) Human major vault protein(MVP)ELISA Kit |
|
GA-E1666HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human major vault protein(MVP)ELISA Kit |
|
GA-E1666HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Major Vault Protein (MVP) ELISA Kit |
|
SEB764Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5402.92 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Major Vault Protein (MVP) in serum, plasma, tissue homogenates and other biological fluids. |
Human Major Vault Protein (MVP) ELISA Kit |
|
SEB764Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 550.13 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Major Vault Protein (MVP) in serum, plasma, tissue homogenates and other biological fluids. |
Human Major Vault Protein (MVP) ELISA Kit |
|
SEB764Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 734.46 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Major Vault Protein (MVP) in serum, plasma, tissue homogenates and other biological fluids. |
Human Major Vault Protein (MVP) ELISA Kit |
|
SEB764Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2945.08 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Major Vault Protein (MVP) in serum, plasma, tissue homogenates and other biological fluids. |
Human Major Vault Protein (MVP) ELISA Kit |
|
4-SEB764Hu |
Cloud-Clone |
-
EUR 5463.60
-
EUR 2886.00
-
EUR 735.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Major Vault Protein (MVP) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
 Antibody) Major Vault Protein (MVP) Antibody |
|
20-abx001613 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx109322 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx113585 |
Abbexa |
|
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx129080 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Major Vault Protein (MVP) Antibody |
|
abx032736-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Major Vault Protein (MVP) Antibody |
|
abx032736-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Major Vault Protein (MVP) Antibody |
|
abx033927-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Major Vault Protein (MVP) Antibody |
|
abx033927-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Major Vault Protein (MVP) Antibody |
|
abx025511-100ul |
Abbexa |
100 ul |
EUR 627.6 |
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx225299 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx241893 |
Abbexa |
|
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx242151 |
Abbexa |
|
|
|
|
Major Vault Protein (MVP) Antibody |
|
20-abx173444 |
Abbexa |
|
|
|
|
) Recombinant Major Vault Protein (MVP) |
|
4-RPB764Hu01 |
Cloud-Clone |
-
EUR 599.54
-
EUR 283.20
-
EUR 1918.27
-
EUR 719.42
-
EUR 1318.85
-
EUR 476.40
-
EUR 4615.68
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Major Vault Protein expressed in: E.coli |
 Major Vault Protein Antibody / MVP |
|
F54845-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 165 |
Major Vault Protein Antibody / MVP |
|
F54845-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 379 |
 MVP Antibody / Major Vault Protein |
|
V3042-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3042-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3042SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3043-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: MVP is required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. |
MVP Antibody / Major Vault Protein |
|
V3043-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: MVP is required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. |
MVP Antibody / Major Vault Protein |
|
V3043IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: MVP is required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. |
MVP Antibody / Major Vault Protein |
|
V3043SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: MVP is required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. |
MVP Antibody / Major Vault Protein |
|
V3044-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3044-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3044IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V3044SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V7386-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. [UniProt] |
MVP Antibody / Major Vault Protein |
|
V7386-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. [UniProt] |
MVP Antibody / Major Vault Protein |
|
V7386IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. [UniProt] |
MVP Antibody / Major Vault Protein |
|
V7386SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. [UniProt] |
MVP Antibody / Major Vault Protein |
|
V7393-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V7393-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V7393IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
|
V7393SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
 Protein) Human Major Vault Protein (MVP) Protein |
|
20-abx167838 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2581.20
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 ELISA Kit) Monkey Major Vault Protein (MVP) ELISA Kit |
|
abx359557-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Rabbit Major Vault Protein (MVP) ELISA Kit |
|
abx362163-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Pig Major Vault Protein (MVP) ELISA Kit |
|
abx361368-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Chicken Major Vault Protein (MVP) ELISA Kit |
|
abx356155-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Cow Major Vault Protein (MVP) ELISA Kit |
|
abx515038-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
|
Chicken Major Vault Protein (MVP) ELISA Kit |
|
abx515039-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Mouse Major Vault Protein (MVP) ELISA Kit |
|
abx515041-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
 ELISA Kit) Rat Major Vault Protein (MVP) ELISA Kit |
|
abx515042-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
 Mouse Mvp/ Major vault protein ELISA Kit |
|
E0992Mo |
Sunlong |
1 Kit |
EUR 685.2 |
 Chicken Major vault protein, MVP ELISA KIT |
|
ELI-03485c |
Lifescience Market |
96 Tests |
EUR 1113.6 |
 Bovine Major vault protein, MVP ELISA KIT |
|
ELI-03487b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
 CLIA Kit) Human Major Vault Protein (MVP) CLIA Kit |
|
20-abx493058 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
) ELISA kit for Human MVP (Major Vault Protein) |
|
ELK4970 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Major Vault Protein from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
 Antibody (Biotin)) Major Vault Protein (MVP) Antibody (Biotin) |
|
20-abx105646 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Major Vault Protein (MVP) Antibody (HRP) |
|
20-abx108484 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Major Vault Protein (MVP) Antibody (FITC) |
|
20-abx107063 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 polyclonal antibody) Major vault protein (MVP) polyclonal antibody |
|
ABP-PAB-10900 |
Allele Biotech |
100 ug |
Ask for price |
|
|
(1014) Antibody) Major Vault Protein (MVP)(1014) Antibody |
|
BNC040224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF405S conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC040224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF405S conjugate, Concentration: 0.1mg/mL |
(1032) Antibody) Major Vault Protein (MVP)(1032) Antibody |
|
BNC040225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF405S conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC040225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF405S conjugate, Concentration: 0.1mg/mL |
 (VP2897R) Antibody) Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC042897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF405S conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC042897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF405S conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC050224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF405M conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC050224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF405M conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC050225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF405M conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC050225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF405M conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCA2897-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), APC conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCAP0224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCAP0224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCAP0225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCAP0225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCAP2897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCAP2897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCB0224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Biotin conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCB0224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Biotin conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCB0225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Biotin conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCB0225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Biotin conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCH2897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCH2897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCP0224-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), PerCP conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCP0225-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), PerCP conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCP2897-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), PerCP conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCR0224-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), RPE conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCR0225-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), RPE conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC940224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC940224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC940225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC940225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC942897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC942897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF594 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNCA0224-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), APC conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNCA0225-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), APC conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC802897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF680 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC802897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF680 conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC810224-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNC810224-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC810225-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNC810225-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC812897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNC812897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), CF680R conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCR2897-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), RPE conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNUB0224-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Concentration: 0.2mg/mL |
Major Vault Protein (MVP)(1014) Antibody |
|
BNUB0224-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1014), Concentration: 0.2mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNUB0225-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Concentration: 0.2mg/mL |
Major Vault Protein (MVP)(1032) Antibody |
|
BNUB0225-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Major Vault Protein (MVP)(1032), Concentration: 0.2mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCB2897-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Biotin conjugate, Concentration: 0.1mg/mL |
Major Vault Protein (MVP) (VP2897R) Antibody |
|
BNCB2897-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Major Vault Protein (MVP) (VP2897R), Biotin conjugate, Concentration: 0.1mg/mL |
Human MVP(Major Vault Protein) ELISA Kit
